Post-earnings recap
Reported
Tue, May 2, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
Dexcom's earnings report shows a mixed picture, with a loss per share that slightly missed expectations. However, the stock rose by 2.58%, likely due to management's positive outlook on future growth and innovation. Investors may be encouraged by the company's long-term strategy despite the current EPS miss.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.49 | N/A | -4.46% |
| Revenue | N/A | N/A | N/A |
Management remains focused on future growth opportunities. They acknowledged the current quarter's performance but emphasized their commitment to innovation.
Management highlighted ongoing investments in product innovation.
They expressed confidence in long-term growth despite current challenges.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—